Trials / Completed
CompletedNCT03852563
A Study to Gain Information How Well Dexpanthenol Derma Cream Helps the Face Skin to Recover After Cosmetic Lasering
Evaluation of the Safety and Efficacy of the Product Bepantol® Cream After the Dermatological Procedure in the Face.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- Bayer · Industry
- Sex
- Female
- Age
- 30 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
In this study, researchers want to learn more about the effect of dexpanthenol cream on skin recovery and reduction of skin rash after a dermatological procedure (ablative laser) on the face for treatment of fine wrinkles, scars and open pores in adult women. After the dermatological procedure, participants will return within 3 weeks for 4 visits to the study center to investigate the skin conditions such as redness, irritation, softness and possible side effects. In addition, study participants will be asked about their general acceptance of dexpanthenol cream.
Detailed description
The primary objective is to evaluate the efficacy of the test product to aid skin recovery and reduction of erythema after ablative lasering on the face. Secondary objectives comprise clinical efficacy with respect to skin hydration, softness, vitality, appearance etc. and skin recovery, consumer judgement of product performance and acceptability, and safety.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BAY207543 (Bepanthol) | Product is applied to one hemiface. |
| OTHER | Semisolid vaseline | Product is applied to one hemiface. |
Timeline
- Start date
- 2019-03-18
- Primary completion
- 2019-04-22
- Completion
- 2019-04-22
- First posted
- 2019-02-25
- Last updated
- 2020-04-20
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT03852563. Inclusion in this directory is not an endorsement.